Immunoassay Analyzers Market size was valued at USD 39.5 billion in 2021, at a CAGR of 5.2% during the forecast period 2022-28. Immunoassay analyzers are the instruments which are used in clinical settings, hospitals or maybe the research organizations to run the biochemical tests to detect the concentration of samples. The market for immuno analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating prospects for the global immunoassay analyzers market growth. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardisation, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in global immuno analyzers market are focusing on the new product developments and launches to strengthen their position.
In September 2017 Siemens got CE Mark and launched its Atellica Solution flexible, scalable, automation-ready immunoassay and chemistry analyzer
In March 2016, Diasorin S.p.A. has entered into the agreement to acquire Quest’s Focus Diagnostics, Inc. molecular diagnostic and immunodiagnostic products business.
In September 2014, Sysmex Corp. has launched Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapting the strategies such as acquisitions and collaboration to increase their product portfolio and market share.